Turtle Creek Wealth Advisors LLC acquired a new stake in shares of CME Group Inc. (NASDAQ:CME - Free Report) during the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 19,065 shares of the financial services provider's stock, valued at approximately $5,058,000.
Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Bleakley Financial Group LLC grew its holdings in shares of CME Group by 76.4% in the 1st quarter. Bleakley Financial Group LLC now owns 22,151 shares of the financial services provider's stock worth $5,876,000 after purchasing an additional 9,593 shares during the last quarter. Key Financial Inc grew its position in CME Group by 119.0% during the 1st quarter. Key Financial Inc now owns 127 shares of the financial services provider's stock worth $34,000 after acquiring an additional 69 shares during the last quarter. LRI Investments LLC grew its holdings in shares of CME Group by 16.2% during the first quarter. LRI Investments LLC now owns 409 shares of the financial services provider's stock worth $109,000 after purchasing an additional 57 shares during the last quarter. CWM LLC grew its holdings in shares of CME Group by 24.0% during the first quarter. CWM LLC now owns 56,429 shares of the financial services provider's stock worth $14,970,000 after purchasing an additional 10,906 shares during the last quarter. Finally, Stephens Inc. AR grew its holdings in shares of CME Group by 9.9% during the first quarter. Stephens Inc. AR now owns 2,542 shares of the financial services provider's stock worth $674,000 after purchasing an additional 230 shares during the last quarter. Institutional investors own 87.75% of the company's stock.
Insider Buying and Selling
In related news, Director Daniel G. Kaye sold 500 shares of the stock in a transaction on Thursday, May 22nd. The shares were sold at an average price of $282.42, for a total transaction of $141,210.00. Following the transaction, the director directly owned 3,668 shares of the company's stock, valued at $1,035,916.56. This represents a 12.00% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, General Counsel Jonathan L. Marcus sold 390 shares of the stock in a transaction that occurred on Tuesday, May 20th. The stock was sold at an average price of $277.50, for a total value of $108,225.00. Following the completion of the transaction, the general counsel owned 6,708 shares in the company, valued at approximately $1,861,470. The trade was a 5.49% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 13,400 shares of company stock worth $3,680,610. Corporate insiders own 0.30% of the company's stock.
CME Group Stock Performance
CME stock traded up $1.33 during trading hours on Thursday, hitting $278.86. 627,726 shares of the stock were exchanged, compared to its average volume of 2,171,905. CME Group Inc. has a 12 month low of $193.25 and a 12 month high of $290.79. The company has a 50-day simple moving average of $276.17 and a two-hundred day simple moving average of $260.04. The firm has a market capitalization of $100.49 billion, a P/E ratio of 28.04, a P/E/G ratio of 4.80 and a beta of 0.44. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13.
CME Group (NASDAQ:CME - Get Free Report) last posted its earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share for the quarter, topping analysts' consensus estimates of $2.61 by $0.19. The firm had revenue of $1.64 billion for the quarter, compared to analysts' expectations of $1.56 billion. CME Group had a net margin of 57.71% and a return on equity of 14.03%. The company's revenue was up 10.4% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.50 earnings per share. On average, analysts forecast that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.
CME Group Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Wednesday, June 25th. Investors of record on Monday, June 9th were issued a $1.25 dividend. This represents a $5.00 annualized dividend and a yield of 1.79%. The ex-dividend date was Monday, June 9th. CME Group's payout ratio is presently 50.30%.
Wall Street Analyst Weigh In
Several analysts have recently commented on CME shares. Oppenheimer increased their price target on shares of CME Group from $282.00 to $300.00 and gave the company an "outperform" rating in a research note on Wednesday, June 4th. Morgan Stanley raised their price target on CME Group from $301.00 to $304.00 and gave the company an "overweight" rating in a report on Thursday, April 24th. Bank of America raised their target price on shares of CME Group from $200.00 to $219.00 and gave the company an "underperform" rating in a research note on Wednesday, April 2nd. UBS Group raised their target price on shares of CME Group from $290.00 to $305.00 and gave the company a "buy" rating in a research note on Friday, April 25th. Finally, Citigroup raised their price objective on shares of CME Group from $265.00 to $275.00 and gave the company a "neutral" rating in a research note on Thursday, July 3rd. Four investment analysts have rated the stock with a sell rating, eight have issued a hold rating and five have given a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of "Hold" and an average price target of $261.80.
Get Our Latest Analysis on CME Group
CME Group Profile
(
Free Report)
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Further Reading

Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.